Market Size of Japan Diabetes Care Devices Industry
| Study Period | 2018 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 1.73 Billion |
| Market Size (2029) | USD 2.44 Billion |
| CAGR (2024 - 2029) | 7.26 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Japan Diabetes Care Devices Market Analysis
The Japan Diabetes Care Devices Market size is estimated at USD 1.73 billion in 2024, and is expected to reach USD 2.44 billion by 2029, growing at a CAGR of 7.26% during the forecast period (2024-2029).
Type 1 diabetes is caused by an immune system malfunction, Type 2 diabetes is linked to leading a sedentary lifestyle, which results in the development of inherent resistance to insulin. Hence, Type 1 diabetes can be characterized as insulin-requiring, while Type 2 diabetes can be characterized as insulin-dependent diabetes.
Japan has one of the largest elderly populations in the world which is more susceptible to the onset of type 2 diabetes. As Japan's population continues to age, the prevalence of diabetes increases as well. The monitoring and management of blood glucose levels are on the rise, to avoid negative consequences, such as cardiovascular diseases, kidney disorders, and many other conditions.
The rising prevalence of diabetes in japan has become a significant health concern, driving the demand for diabetes devices. With lifestyle changes, including sedentary behavior, unhealthy eating habits, and an aging population, Italy has witnessed a steady increase in the number of individuals diagnosed with diabetes. According to recent statistics, japan ranks among the Asia countries with a high prevalence of diabetes, with both type 1 and type 2 diabetes contributing to the burden of the disease.
As the diabetes population continues to grow in Japan, there is a parallel surge in the need for effective management and treatment options. Diabetes devices play a crucial role in controlling blood sugar levels and preventing complications associated with diabetes. These medications are favored by many patients due to their convenience, ease of administration, and ability to improve glycemic control.
The demand for diabetes devices reflects the necessity for accessible and efficient treatments to combat the escalating diabetes epidemic in Japan.
Japan Diabetes Care Devices Industry Segmentation
Diabetes care devices are the hardware, equipment, and software used by diabetes patients to regulate blood glucose levels, prevent diabetes complications, lessen the burden of diabetes, and enhance the quality of life. The Japan Diabetes Care Devices Market is segmented into management devices and monitoring devices The report offers the Value (In USD) for the above segments.
| Management Devices | |||||||||||
| |||||||||||
| |||||||||||
| Insulin Syringes | |||||||||||
| Jet Injectors |
| Monitoring Devices | |||||
| |||||
|
Japan Diabetes Care Devices Market Size Summary
The Japan diabetes care devices market is experiencing significant growth, driven by the increasing prevalence of diabetes, particularly among the aging population. As lifestyle changes and sedentary behaviors contribute to a rise in both type 1 and type 2 diabetes cases, the demand for effective monitoring and management devices is on the rise. Continuous glucose monitoring (CGM) systems, insulin cartridges in reusable pens, and other advanced diabetes care devices are becoming essential in managing blood sugar levels and preventing complications. These devices offer convenience, ease of use, and improved glycemic control, making them a preferred choice for many patients. The market is characterized by technological advancements, such as the development of minimally invasive and user-friendly sensors, which are expected to drive further growth.
The Japanese government recognizes diabetes as a healthcare priority, with well-organized medical insurance systems covering all medical fees related to diabetes care. This support, along with the legal approval of insulin therapy by self-injection, has facilitated the adoption of diabetes care devices in the market. Major manufacturers like Roche, Abbott, Novo Nordisk, Dexcom, and Medtronic dominate the market, offering innovative solutions to meet the growing demand. Recent developments, such as Dexcom's G6 CGM and collaborations between Sanofi and Health2Sync, highlight the ongoing efforts to enhance diabetes management through technology. The market's consolidation and the introduction of new features and products indicate a robust and evolving landscape for diabetes care devices in Japan.
Japan Diabetes Care Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.3 Market Restraints
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Suppliers
-
1.4.2 Bargaining Power of Consumers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products and Services
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 Management Devices
-
2.1.1 Insulin Pump
-
2.1.1.1 Technology
-
2.1.1.1.1 Tethered Insulin Pump
-
2.1.1.1.2 Tubeless Insulin Pump
-
-
2.1.1.2 Component
-
2.1.1.2.1 Insulin Pump Device
-
2.1.1.2.2 Insulin Pump Reservoir
-
2.1.1.2.3 Infusion Set
-
-
-
2.1.2 Insulin pens
-
2.1.2.1 Cartridges in Reusable Pens
-
2.1.2.2 Insulin Disposable Pens
-
-
2.1.3 Insulin Syringes
-
2.1.4 Jet Injectors
-
-
2.2 Monitoring Devices
-
2.2.1 Self-monitoring Blood Glucose
-
2.2.1.1 Glucometer Devices
-
2.2.1.2 Blood Glucose Test Strips
-
2.2.1.3 Lancets
-
-
2.2.2 Continuous Glucose Monitoring
-
2.2.2.1 Sensors
-
2.2.2.2 Durables (Receivers and Transmitters)
-
-
-
Japan Diabetes Care Devices Market Size FAQs
How big is the Japan Diabetes Care Devices Market?
The Japan Diabetes Care Devices Market size is expected to reach USD 1.73 billion in 2024 and grow at a CAGR of 7.26% to reach USD 2.44 billion by 2029.
What is the current Japan Diabetes Care Devices Market size?
In 2024, the Japan Diabetes Care Devices Market size is expected to reach USD 1.73 billion.
